Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New thiazole derivatives for inhibiting cell adhesion

June 9, 2000

Data presented this week on antiproliferative activity and mechanism of action of CT-3

June 9, 2000

Bioniche uncovers new class of agents with anticancer activity

June 9, 2000

Discovery of new generation of ribozymes and compound with potent activity against HER-2 oncogene

June 9, 2000

ISIS-2503 under clinical evaluation, alone and in combination, for advanced cancers

June 8, 2000

Available clinical data on tgDCC-E1A summarized; new formulation heads for clinic

June 8, 2000

SafeScience initiates phase II trial for colorectal carcinoma drug candidate

June 8, 2000

Lexicon Genetics discovers gene controlling onset of aging, cancer in mice

June 8, 2000

Eos Biotechnology and Aventis Pasteur enter cancer vaccine agreement

June 7, 2000

ISIS-3521 to be advanced to phase III trials for NSCLC based on recent results

June 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...